OCIAD2 anticorps (N-Term)

N° du produit ABIN6991217

Détail du produit anti-OCIAD2 anticorps

Antigène: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Épitope: N-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp OCIAD2 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF)

Purification: OCIAD2 Antibody is affinity chromatography purified via peptide column.

Immunogène: OCIAD2 antibody was raised against a 17 amino acid synthetic peptide from near the amino terminus of human OCIAD2. The immunogen is located within the first 50 amino acids of OCIAD2.

Isotype: IgG

Information d'application

Indications d'application: OCIAD2 antibody can be used for detection of OCIAD2 by Western blot at 0.5 - 1 μ,g/mL. Antibody can also be used for immunoflourescence starting at 20 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.

Antibody validated: Western Blot in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: OCIAD2 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: OCIAD2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur OCIAD2

Antigène: OCIAD2 (OCIA Domain Containing 2 (OCIAD2))

Autre désignation: OCIAD2 (OCIAD2 Produits)

Synonymes: anticorps 1810027I20Rik, anticorps OCIA domain containing 2 L homeolog, anticorps OCIA domain containing 2, anticorps ociad2.L, anticorps OCIAD2, anticorps Ociad2

Sujet: OCIAD2 Antibody: OCIAD2 was identified by its sequence similarity with OCIAD1, and together OCIAD1 and OCIAD2 form the OCIA domain family. OCIAD2 mRNA was found to be expressed at higher levels in invasive adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component (BAC) of the lung. Loss of OCIAD2 expression was significantly correlated with lymphatic invasion, blood vessel invasion, and lymph node metastasis, indicating that OCIAD2 may play a role in cell adhesion and prevention of cell migration. While the function of OCIAD2 is still unknown, its expression in adenocarcinoma with BAC component is significantly associated with a favorable prognosis and may serve as a marker for selecting tumors that are treatable by limited surgery.

ID gène: 132299

NCBI Accession: NP_001014446

UniProt: Q56VL3